IMS MAXIMS

Name: IMS MAXIMS
Brand: IMS MAXIMS

Helping to improve health outcomes through the use of technology.

Est 1986|15 Ref Customers

LinkedIn 3K|Website|FTEs 88|HQ Dun Laoghaire, County Dublin, IE

Published Oct 15, 2026

01Common complaints

- If you need abundant, easily accessible third-party buyer reviews and benchmarks - IMS MAXIMS has limited public customer reviews on major platforms like G2 (0 reviews listed), which makes it harder to validate day-to-day usability and support outcomes via public sources. - If SOC 2 Type II (and/or ISO 27017/27018) is mandatory for your procurement - IMS MAXIMS publicly documents ISO 27001, ISO 9001, and Cyber Essentials, but SOC 2 and cloud-privacy specific ISO certifications are not clearly documented in the sampled sources. - If you intend to self-host and rely heavily on the open-source path (openMAXIMS) without internal engineering capacity - Community discussions indicate non-trivial setup, build, and runtime hurdles for the open-source variant, which can negate the expected benefits for organisations without sufficient technical resources. - If you want a global mega-vendor ecosystem and labor market depth - Epic, Oracle Health (Cerner), and similar global vendors typically offer broader international ecosystems, more third-party integrations, and larger pools of certified resources. - If you need highly mature, proven AI documentation automation today - The vendor has an AI initiative; buyers should validate maturity and measurable outcomes with references before committing. - Current limitations acknowledged by the vendor - No explicit "known issues" page was identified in the sampled official sources. - Features on the roadmap - The vendor's "MAXIMS AI Lab" indicates ongoing exploration and integration of AI capabilities; specific general availability dates and productised features are not clearly documented publicly. - Scale limitations - Scale-related metrics are not publicly documented in the sampled sources. Buyers should request: - Performance benchmarks (concurrent users, peak transaction loads) - Database and hosting reference architectures - DR/RTO/RPO commitments - Security or compliance gaps - Publicly documented: ISO 27001, Cyber Essentials, ISO 9001. - Not publicly documented (in sampled sources): SOC 2, ISO 27017/27018, detailed SSO/SCIM documentation, and a public security whitepaper. - Technical debt / architectural limitations mentioned in reviews - Open-source community threads indicate repository and build issues historically for openMAXIMS (e.g., corrupted files, difficulty launching). - API limitations or integration constraints - The vendor states support for open APIs and integration capabilities, but specifics (FHIR resources supported, API versioning, rate limits, eventing) are not detailed in the sampled pages and should be requested.

Deal disqualifiers (poor fit)

Organisations that require SOC 2 Type II or specific cloud-privacy ISO certifications where those are mandatory and cannot be substituted by other attestations
Buyers requiring extensive public third-party buyer review coverage on mainstream platforms as a primary procurement criterion
Organisations intending to adopt the open-source variant without in-house engineering resources to manage build and operational tasks

02Why they buy

- Stated support for open standards and interoperability - The vendor states support for open standards and notes involvement with INTEROPen in public materials. - Modular PAS/EPR architecture - MAXIMS is described as modular and configurable, allowing incremental adoption and integration with existing systems. - Open-source option (openMAXIMS) - The company has previously released an open-source variant and discussed a community model; this provides a potential route for code access and local adaptation, with the caveat that operational responsibility may shift to adopters. - Where competitors may have clearer advantages - System C and larger vendors highlight broader module sets, cloud-native approaches, and larger ecosystems that may be preferable for buyers prioritising those attributes.

03Field reports

- Important limitation on review availability - Major software review platforms have limited or no customer reviews for IMS MAXIMS. - G2 lists IMS MAXIMS with no customer reviews, explicitly stating there are not enough reviews to provide buying insight. - TrustRadius did not surface an obvious IMS MAXIMS product review page in accessible search results (site search itself is accessible, but IMS MAXIMS–specific review content was not found/verified in this crawl). - Gartner Peer Insights: no IMS MAXIMS review content was retrieved in accessible results; Gartner pages can be access-restricted. - Direct quotes (balanced; note that many available "quotes" are employee/employer-side rather than buyer reviews) - Glassdoor (employee reviews; not customer reviews): - Positive: "friendly people work at IMS" - Negative: "Management only cares about arbitrary visual metrics, rather than actual results" - Mixed/operational: "Documentation could be better managed" - Indeed (employee review; not customer review): - Positive: "Good people good product" - Notes: "Full range of EPR functionality including A&E and Order Comms. New developments in mobile technologies" - Community/open-source technical thread (developer/operator perspective on openMAXIMS, not MAXIMS commercial product support): - Reports of installation and runtime issues in the open-source variant (e.g., corrupted files, difficulty getting the application to launch). - Common criticisms and complaints (from available sources) - Public customer review volume is too low to confidently quantify "most common" complaints from customers. - Observable issues: - Documentation quality concerns appear in employee reviews. - The open-source variant (openMAXIMS) has historical community reports of build/run difficulties and repository quality issues. - Why customers chose this product over alternatives (inferred from press/vendor narrative) - UK/Ireland workflow alignment and participation in NHS-related programs - Messaging around interoperability and open standards and an open-source option (openMAXIMS) - Ability to deploy modularly and integrate with existing systems rather than replacing them wholesale - Why some customers left for competitors (churn reasons) - Not directly evidenced in accessible customer reviews in this research set. - Specific outcomes customers achieved (with metrics when available) - A historical source asserted Taunton and Somerset NHS Foundation Trust would realize a substantial annual savings by 2018 after deploying openMAXIMS; this claim was not validated with an original primary source in the collected materials and should be treated as unverified. - Digital Health reported that Ramsay Health Care UK achieved consistent outcome data for benchmarking after rollout (qualitative reporting). - Deal-breakers and reasons customers didn’t purchase - Not directly evidenced via accessible customer review data.

Ramsay Health Care UK (private healthcare provider)

- Reporting indicates the MAXIMS EPR was rolled out across multiple Ramsay Health Care UK hospital sites and that the EPR provided outcome data for benchmarking. - Critical evaluation: - Benefits in published summaries are mostly qualitative. - No independent ROI methodology or detailed metrics were published in the materials reviewed. - Buyers should request site-specific adoption metrics (documentation time, medication error rates, discharge turnaround) and user satisfaction results.

States of Guernsey / other go-lives

The vendor publishes go-live stories on its site and news feed.
Critical evaluation:
- Vendor case studies typically emphasize successful outcomes; buyers should request:
  - Baseline vs post-go-live metrics
  - Clinical safety incident rates and hazard log summaries (appropriately anonymized)
  - Lessons learned and items that required remediation

Open source (openMAXIMS) as a strategic case

- IMS MAXIMS released an open-source variant historically under AGPL, and press coverage discussed plans for community involvement. - Critical evaluation: - Open source can reduce licensing costs and increase transparency, but it may shift operational burden to adopters if internal capability is insufficient. - Community discussion indicates practical hurdles in getting openMAXIMS running, which can reduce the practical benefits for organizations without engineering capacity.

04Best fit

Organisation sizes

Likely fit spans:
- Small clinics (vendor statements)
- Mid-sized hospitals
- Multi-site organisations and integrated care systems across multiple trusts (vendor statements)
Practical buyer reality: a stronger indicator of fit is governance and implementation capacity rather than raw employee count.

Industries and verticals

Public-sector acute hospitals
Community care and mental health services
Independent/private hospitals

Roles and personas

Decision makers:
- CIO / CCIO / CNIO
- Director of Digital Transformation
- COO / Chief Operating Officer
- Clinical Safety Officer / Governance leads
- Procurement and information governance leads
End users:
- Nurses, physicians/consultants
- Bed managers, admissions/registration staff
- Coding and finance teams
- Allied health professionals

Pain points the product addresses

Consolidation of patient records across departments
Bed management, patient flow, and discharge processes
Point-of-care clinical documentation via mobile-enabled applications
Integration with existing legacy subsystems to avoid wholesale replacement

Qualification criteria (good fit)

UK/Ireland standards alignment is a core requirement
Need for modular rollout and integration with existing systems
Appetite for structured clinical safety governance and documentation
Capacity to run structured change management and training programs

05The pitch

What the product does (core value proposition in objective terms)

IMS MAXIMS provides a browser-based, modular Patient Administration System (PAS) and Electronic Patient Record (EPR) platform for healthcare providers in the UK and Ireland.
The vendor describes MAXIMS as a configurable EPR/PAS suite that can be deployed end-to-end or in modules (e.g., bed management, clinical noting, order communications) and integrated with other systems rather than requiring a full replacement of existing systems.

Target market and market positioning

- Primary market appears to be public-sector healthcare (NHS trusts and equivalents), plus independent/private hospitals and smaller clinics in the UK and Ireland. - Positioning elements noted in vendor materials and press coverage: - Claims of clinician-influenced workflows and usability - Emphasis on interoperability and use of open standards - Vendor statements that deployments can be faster than some large enterprise EHR replacements (vendor claim) - References to alignment with digital maturity frameworks and national health programs

Get a comprehensive analysis of IMS MAXIMS including market position, competitive landscape, adoption trends, and peer benchmarks.

Download full report →